Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Christine L. Baker's publication output changed over time?
ScholarIQpublication output · 2006–2024
Output grew0% over the shown period — from 1 works in 2006 to 1 in 2024.
1
1
1
1
1
1
1
1
1
1
2006200720082009201120132014201720212024
What are the most-cited papers on Christine L. Baker?
ScholarIQmost cited works
Frequency of <i>KRAS</i>, <i>BRAF</i>, and <i>NRAS</i> mutations in colorectal cancer
Cecily P. Vaughn, Scott D. ZoBell, Larissa V. Furtado, Christine L. Baker, Wade S. Samowitz
S200862508. 2011381 Citations
Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire
Joseph C. Cappelleri, Andrew G. Bushmakin, Christine L. Baker, Elizabeth Merikle, Abayomi O. Olufade, David G. Gilbert
Addictive Behaviors. 2006246 Citations
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt
Robert West, Christine L. Baker, Joseph C. Cappelleri, Andrew G. Bushmakin
Psychopharmacology. 2007202 Citations
Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model
Paul Howard, Christopher P. Knight, Annabel Boler, Christine L. Baker
PharmacoEconomics. 200899 Citations
Risk assessment of readmissions following an initial COPD-related hospitalization
Su, Christine L. Baker, Kelly H. Zou
International Journal of COPD. 201396 CitationsOPEN ACCESS
Related on ScholarIQ
Pfizer (United States)
Institution
Frequency of <i>KRAS</i>, <i>BRAF</i>, and <i>NRAS</i> mutations in colorectal cancer
Paper
Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire
Paper
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt
Paper
Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model
Paper
Risk assessment of readmissions following an initial COPD-related hospitalization
Paper